Abstract:To determine practicing physicians' strategies for diagnosing and managing uncomplicated urinary tract infection, we surveyed physicians in general internal medicine, family practice, obstetrics and gynecology, and emergency medicine in four states. Responses differed significantly by respondents' specialty. For example, nitrofurantoin was the antibiotic of first choice for 46% of obstetricians, while over 80% in the other specialties chose trimethoprim-sulfamethoxazole. Most surveyed said they do not usually … Show more
“…16 An antibiotic agent is prescribed in 67% of visits, and a urinalysis is ordered in 81%, 16 with wide variations in physician management. 17,18 As many as 40% of antibiotics prescribed may be unnecessary because the subsequent urine culture result is negative. 4 The cystitis decision aid is a simple clinical approach that could reduce practice variation as well as unnecessary antibiotic prescriptions and urine culture testing.…”
Section: Commentmentioning
confidence: 99%
“…5 This latter approach was associated with a high rate of unnecessary antibiotic use in the present study. In the context of increasing uropathogen antibiotic resistance 19 and lack of clinical agreement about how to manage acute cystitis, 17,18 practical and validated strategies that can help physicians use antibiotics judiciously could be clinically useful.…”
Background: In a previous study, use of a decision aid based on 4 clinical items would have reduced unnecessary antibiotic prescriptions for acute cystitis by 30% compared with usual physician care.
Methods:We assessed the decision aid in a different population of females seen in community-based practice. Between April 7, 2002, and March 20, 2003, 225 Canadian family physicians recorded clinical findings, urine dip test results, and treatment decisions for 331 females with suspected cystitis. The number of decision aid items present was determined for each patient, and the sensitivity and specificity of decision aid recommendations for empirical antibiotics were determined using the gold standard of a positive urine culture result (Ն10 2 colony-forming units per milliliter). Total antibiotic prescriptions, unnecessary prescriptions (for negative culture results), and recommendations for urine cultures were determined and compared with physician management.Results: Three of the original decision aid variables (dys-uria, the presence of leukocytes [greater than a trace amount], and the presence of nitrites [any positive]) were associated with having a positive urine culture result (P Յ.001), but 1 variable (symptoms for 1 day) was not (P =.96). A simplified decision aid incorporating the 3 significant variables (empirical antibiotics without culture if Ն2 variables present; otherwise obtain a culture and wait for results) had a sensitivity of 80.3% (167/ 208) and a specificity of 53.7% (66/123). Following decision aid recommendations would have reduced antibiotic prescriptions by 23.5%, unnecessary prescriptions by 40.2%, and urine cultures by 59.0% compared with physician care (PϽ .001 for all).
Conclusion:A simple 3-item decision aid could significantly reduce unnecessary antibiotic drug prescriptions and urine culture testing in females with symptoms of acute cystitis.
“…16 An antibiotic agent is prescribed in 67% of visits, and a urinalysis is ordered in 81%, 16 with wide variations in physician management. 17,18 As many as 40% of antibiotics prescribed may be unnecessary because the subsequent urine culture result is negative. 4 The cystitis decision aid is a simple clinical approach that could reduce practice variation as well as unnecessary antibiotic prescriptions and urine culture testing.…”
Section: Commentmentioning
confidence: 99%
“…5 This latter approach was associated with a high rate of unnecessary antibiotic use in the present study. In the context of increasing uropathogen antibiotic resistance 19 and lack of clinical agreement about how to manage acute cystitis, 17,18 practical and validated strategies that can help physicians use antibiotics judiciously could be clinically useful.…”
Background: In a previous study, use of a decision aid based on 4 clinical items would have reduced unnecessary antibiotic prescriptions for acute cystitis by 30% compared with usual physician care.
Methods:We assessed the decision aid in a different population of females seen in community-based practice. Between April 7, 2002, and March 20, 2003, 225 Canadian family physicians recorded clinical findings, urine dip test results, and treatment decisions for 331 females with suspected cystitis. The number of decision aid items present was determined for each patient, and the sensitivity and specificity of decision aid recommendations for empirical antibiotics were determined using the gold standard of a positive urine culture result (Ն10 2 colony-forming units per milliliter). Total antibiotic prescriptions, unnecessary prescriptions (for negative culture results), and recommendations for urine cultures were determined and compared with physician management.Results: Three of the original decision aid variables (dys-uria, the presence of leukocytes [greater than a trace amount], and the presence of nitrites [any positive]) were associated with having a positive urine culture result (P Յ.001), but 1 variable (symptoms for 1 day) was not (P =.96). A simplified decision aid incorporating the 3 significant variables (empirical antibiotics without culture if Ն2 variables present; otherwise obtain a culture and wait for results) had a sensitivity of 80.3% (167/ 208) and a specificity of 53.7% (66/123). Following decision aid recommendations would have reduced antibiotic prescriptions by 23.5%, unnecessary prescriptions by 40.2%, and urine cultures by 59.0% compared with physician care (PϽ .001 for all).
Conclusion:A simple 3-item decision aid could significantly reduce unnecessary antibiotic drug prescriptions and urine culture testing in females with symptoms of acute cystitis.
“…In the recent years, several studies have shown specific risk factors for recurrent AUC [7,8] and large studies revealed its microbial etiology. Clinical tests for diagnosing AUC vary widely, depending on comorbidities and different treatment strategies [9,10,11]. …”
“…Often this test is used in conjunction with or in place of a urine culture in the diagnosis of a UTI. However, a recent study found many practicing clinicians use different standards to determine the presence or absence of a UTI, most not updated on current literature 3 . To further complicate matters, the level of automation in urinalysis is increasing and accepted cut-off values differ for these more sensitive methods.…”
Dysuria is a common presenting complaint of women and urinalysis is a valuable tool in the initial evaluation of this presentation. Clinicians need to be aware that pyuria is the best determinate of bacteriuria requiring therapy and that values significant for infection differ depending on the method of analysis. A hemocytometer yields a value of 10 WBC/mm 3 significant for bacteriuria, while manual microscopy studies show 8 WBC/high-power field reliably predicts a positive urine culture. In cases of uncomplicated symptomatic urinary tract infection, a positive value for nitrites and leukocyte esterase by urine dipstick can be treated without the need for a urine culture. Automated urinalysis used widely in large volume laboratories provides more sensitive detection of leukocytes and bacteria in the urine. With automated microscopy, a value of > 2 WBC/hpf is significant pyuria indicative of inflammation of the urinary tract. In complicated cases such as pregnancy, recurrent infection or renal involvement, further evaluation is necessary including manual microscopy and urine culture with sensitivities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.